000 01209 a2200313 4500
005 20250517111846.0
264 0 _c20160921
008 201609s 0 0 eng d
022 _a1085-5629
024 7 _a10.12788/j.sder.2016.022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStrober, Bruce E
245 0 0 _aWhy Biologic Therapies Sometimes Lose Efficacy.
_h[electronic resource]
260 _bSeminars in cutaneous medicine and surgery
_cJun 2016
300 _aS78-80 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdalimumab
_xadministration & dosage
650 0 4 _aBiological Products
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aDermatologic Agents
_xtherapeutic use
650 0 4 _aDrug Therapy, Combination
650 0 4 _aEvidence-Based Medicine
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aPsoriasis
_xdrug therapy
650 0 4 _aTreatment Outcome
773 0 _tSeminars in cutaneous medicine and surgery
_gvol. 35
_gno. 4 Suppl 4
_gp. S78-80
856 4 0 _uhttps://doi.org/10.12788/j.sder.2016.022
_zAvailable from publisher's website
999 _c26328945
_d26328945